Rosenkranz, Kari M.
Ballman, Karla
McCall, Linda
McCarthy, Colleen
Kubicky, Charlotte D.
Cuttino, Laurie
Hunt, Kelly K.
Giuliano, Armando
Van Zee, Kimberly J.
Haffty, Bruce
Boughey, Judy C.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study
https://doi.org/10.1245/s10434-020-08893-w
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance)
https://doi.org/10.1200/jco.22.02553
Funding for this research was provided by:
National Cancer Institute (Award Numbers U10CA180821, U10CA180882, UG1CA23)
Article History
Received: 14 May 2020
Accepted: 4 July 2020
First Online: 22 July 2020
Disclosures
: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award nos. U10CA180821 and U10CA180882; UG1CA233290, UG1CA233329, and UG1CA232760. Dr. Karla Ballman discloses an NCI grant to the Alliance Cooperative Cancer Trial group. Dr. Kelly Hunt discloses a Medical Advisory Board role for Armada Health and Merck & Co., and also disclosures research funding to her institution from Armada Health, Merck & Co., Endomagnetics, Lumicell, and OncoNano. Dr. Armando Giuliano discloses an Alliance grant. Dr. Judy Boughey discloses funding from the NCI to Alliance for Clinical Trials in Oncology group for travel to Alliance meetings. All other authors had no disclosures. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. ExternalRef removed.